[Atenolol in treatment of patients with airway obstruction].

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)

R Chazan

ABSTRACT

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

MATERIALI

Numero di prodotto

Marchio

Descrizione del prodotto

A7655

Sigma-Aldrich

Atenolol, ≥98% (TLC), powder

A-072

Supelco

Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

1044403

USP

Atenolol, United States Pharmacopeia (USP) Reference Standard

A1340000

Atenolol, European Pharmacopoeia (EP) Reference Standard